Overview
SPTX market data
Price History
SPTX price chart · 1M
- O
- 25.07
- H
- 28.16
- L
- 25.07
- C
- 27.85
- Vol
- 9,006.00
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $25.07
- Previous Close
- $24.63
- Day High
- $28.16
- Day Low
- $25.07
- 52 Week High
- $28.16
- 52 Week Low
- $14.94
- 7 Day Return
- +14.51%
- 30 Day Return
- +35.99%
- 90 Day Return
- +47.94%
- 1 Year Return
- +42.60%
- Daily Notional Volume
- $250.8K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.06 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.16 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $14.85 – $26.32 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.3B.
Company News
Seaport Therapeutics shares are trading higher after Jones Trading initiated coverage on the stock with a Buy rating and announced a $32 price target.Benzinga · Aug 26, 2026, 5:36 PM
Jones Trading Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $32Benzinga · Aug 26, 2026, 3:15 PM
HC Wainwright & Co. Reiterates Buy on Seaport Therapeutics, Maintains $50 Price TargetBenzinga · Aug 20, 2026, 11:25 AM
Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) EstimateBenzinga · Aug 3, 2026, 11:05 AM
8-K filing — Seaport Therapeutics, Inc. (SPTX)SEC EDGAR · Aug 3, 2026, 11:03 AM
HC Wainwright & Co. Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $50Benzinga · Jul 15, 2026, 10:42 AM
Seaport Therapeutics Q1 EPS $(10.34) Misses $(9.48) EstimateBenzinga · Jun 8, 2026, 11:30 AM